The 4th Congress of Pathologists of Bosnia and Herzegovina, featuring international participation, will be held in Tuzla from May 22 to 24, 2025.
This prestigious event will bring together leading national and international experts in pathology and related medical disciplines. The congress will serve as a platform to present the latest developments in diagnostic models, biomarkers, and technologies that are shaping the future of pathology.
The scientific and professional program includes plenary sessions, keynote lectures by invited speakers, and satellite symposia focusing on contemporary diagnostic tools essential for selecting optimal treatment strategies. Highlighted topics will include advancements in hematopathology, pulmonary, urogenital, gynecological, gastrointestinal, and neuropathology, with an emphasis on the latest WHO classifications. Special attention will be given to innovative diagnostic approaches and the integration of molecular-genetic testing into routine clinical practice.
In addition to its rich scientific program, the Congress will also serve as a valuable platform for networking, idea exchange, and strengthening collaboration among experts from Bosnia and Herzegovina and the wider region. The informal segments of the event are designed to foster meaningful connections and professional partnerships.
According to the president of the Organizing Committee, Assoc. Prof. Dr. Azra Sadiković, the Congress will place particular emphasis on molecular pathology—one of the most dynamic and rapidly evolving branches of modern pathology. This field is increasingly integral to precise diagnostics, patient stratification, and personalized treatment, especially in the context of oncology.
“The Fourth Congress of Pathologists of Bosnia and Herzegovina offers an outstanding opportunity for the exchange of knowledge, experiences, and ideas among professionals across various medical disciplines. We are confident that the multidisciplinary focus and spotlight on cutting-edge developments in molecular pathology will significantly enhance diagnostic capabilities and treatment outcomes in our country and the region,” emphasized Assoc. Prof. Dr. Sadiković.
